Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration ’s Adverse Event Reporting System
ConclusionsInclusion of lawyer-submitted reports in FAERS did not meaningfully distort known safety signals for two drugs subject to high-profile tort litigation for other AEs.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Absorica | Accutane | Atorvastatin Calcium | Crestor | Drugs & Pharmacology | Legislation | Lipitor | Medical Law | Rhabdomyolysis | Rosuvastatin | Statin Therapy | Zivast